Monte Rosa Therapeutics initiated with Buy at H.C. Wainwright
Upside potential supported by favorable target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential supported by favorable target.
What happened, with direct paths to the underlying reporting
Target 25; posted price 11.93; bullish setup supported by target above price.
Target: $25
Posted price: $11.93
Analyst firm: H.C. Wainwright
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.